Correlation Between Akari Therapeutics and Bolt Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Bolt Biotherapeutics, you can compare the effects of market volatilities on Akari Therapeutics and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Bolt Biotherapeutics.
Diversification Opportunities for Akari Therapeutics and Bolt Biotherapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akari and Bolt is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Bolt Biotherapeutics go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Bolt Biotherapeutics
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to generate 2.02 times more return on investment than Bolt Biotherapeutics. However, Akari Therapeutics is 2.02 times more volatile than Bolt Biotherapeutics. It trades about 0.11 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.23 per unit of risk. If you would invest 121.00 in Akari Therapeutics PLC on November 2, 2024 and sell it today you would earn a total of 11.00 from holding Akari Therapeutics PLC or generate 9.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Bolt Biotherapeutics
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Bolt Biotherapeutics |
Akari Therapeutics and Bolt Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Bolt Biotherapeutics
The main advantage of trading using opposite Akari Therapeutics and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |